United Therapeutics Corporation:企業の戦略・SWOT・財務分析

◆英語タイトル:United Therapeutics Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4732
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

United Therapeutics Corporation – Strategy, SWOT and Corporate Finance Report
Summary

United Therapeutics Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

United Therapeutics Corporation (United Therapeutics or ‘the company’) is a biotechnology company focused on the development and commercialization of products to address the unmet medical needs of patients with chronic and life threatening conditions. The product portfolio of the company includes Remodulin Injection; Tyvaso (treprostinil) Inhalation Solution; Adcirca (tadalafil) Tablets; Orenitram (treprostinil) extended release tablets; PLX Cells; Replacement Lungs- Transplantation and Self-Injectable Prostacyclin Analogues- PAH. United Therapeutics sells products through specialty pharmaceutical distributors in the US. The company operates in Europe, Israel and the Middle East, Asia and South and Central America. United Therapeutics is headquartered in Silver Spring, Maryland, the US.

Scope

- Detailed information on United Therapeutics Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting United Therapeutics Corporation in the form of a SWOT analysis
- An in-depth view of the business model of United Therapeutics Corporation including a breakdown and examination of key business segments
- Intelligence on United Therapeutics Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about United Therapeutics Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of United Therapeutics Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess United Therapeutics Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on United Therapeutics Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
United Therapeutics Corporation: Company Overview
United Therapeutics Corporation: Overview and Key Facts
United Therapeutics Corporation: Overview
United Therapeutics Corporation: Key Facts
United Therapeutics Corporation: Key Employees
United Therapeutics Corporation: Key Employee Biographies
United Therapeutics Corporation: Major Products and Services
United Therapeutics Corporation: Company History
United Therapeutics Corporation: Management Statement
United Therapeutics Corporation: Locations and Subsidiaries
United Therapeutics Corporation: Key Competitors
United Therapeutics Corporation: Company Analysis
United Therapeutics Corporation: Business Description
United Therapeutics Corporation: SWOT Analysis
United Therapeutics Corporation: SWOT Overview
United Therapeutics Corporation: Strengths
United Therapeutics Corporation: Weaknesses
United Therapeutics Corporation: Opportunities
United Therapeutics Corporation: Threats
United Therapeutics Corporation: Corporate Financial Deals Activity
United Therapeutics Corporation: Financial Deals Overview
United Therapeutics Corporation: Targets and Partners
United Therapeutics Corporation: Top Deals 2016 – 2020YTD*
United Therapeutics Corporation: Advisors
United Therapeutics Corporation: Top Legal Advisors
United Therapeutics Corporation: Mergers and Acquisitions
United Therapeutics Corporation: Corporate Venturing
United Therapeutics Corporation: Partnership
United Therapeutics Corporation: Recent Developments
United Therapeutics Corporation: News and Events Summary
United Therapeutics Corporation: Business Expansion
United Therapeutics Corporation: Corporate Governance
United Therapeutics Corporation: Financial Deals
United Therapeutics Corporation: Financial Performance
United Therapeutics Corporation: Grants
United Therapeutics Corporation: Market Developments
United Therapeutics Corporation: Research & Development
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: United Therapeutics Corporation: Key Facts
Table 2: United Therapeutics Corporation: Key Employees
Table 3: United Therapeutics Corporation: Company History
Table 4: United Therapeutics Corporation: Locations and Subsidiaries
Table 5: United Therapeutics Corporation: Key Competitors
Table 6: United Therapeutics Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 7: United Therapeutics Corporation: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: United Therapeutics Corporation: M&A Average Deal Size - Value (US$m)
Table 9: United Therapeutics Corporation: Targets and Partners
Table 10: United Therapeutics Corporation: Top Deals 2016 - 2020YTD*
Table 11: United Therapeutics Corporation: Legal Advisor Ranking by Value (US$m)
Table 12: United Therapeutics Corporation: M&A Volume and Value Trend (2016 - YTD*2020)
Table 13: United Therapeutics Corporation: M&A Activity by Geography (2016 - YTD*2020)
Table 14: United Therapeutics Corporation: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Table 15: United Therapeutics Corporation: Corporate Venturing by Geography (2016 - YTD*2020)
Table 16: United Therapeutics Corporation: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 17: United Therapeutics Corporation: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 18: United Therapeutics Corporation: News and Events Summary
Table 19: United Therapeutics Corporation: Business Expansion
Table 20: United Therapeutics Corporation: Corporate Governance
Table 21: United Therapeutics Corporation: Financial Deals
Table 22: United Therapeutics Corporation: Financial Performance
Table 23: United Therapeutics Corporation: Grants
Table 24: United Therapeutics Corporation: Market Developments
Table 25: United Therapeutics Corporation: Research & Development

★海外企業調査レポート[United Therapeutics Corporation:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Max Delbruck Center for Molecular Medicine:製薬・医療:M&Aディール及び事業提携情報
    Summary Max Delbruck Center for Molecular Medicine (MDC) is a biomedical research center that offers translating discoveries from molecular research into applications. The company’s research area services offer for cancer research, cardiovascular and metabolic disease, diseases of the nervous system …
  • Confluent Medical Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary Confluent Medical Technologies Inc (CMT), formerly Nitinol Devices and Components Inc is a medical device company that manufactures and markets nitinol devices and balloon catheters. The company’s products include wire, strip, sheet, tubing, and bar. Its development services include finite e …
  • SK Holdings Co Ltd (034730):企業の財務・戦略的SWOT分析
    SK Holdings Co Ltd (034730) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • LycoRed Ltd:戦略・SWOT・企業財務分析
    LycoRed Ltd - Strategy, SWOT and Corporate Finance Report Summary LycoRed Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Celixir Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Celixir Ltd (CTL), formerly Cell Therapy Ltd is a biotechnology company that discovers and develops regenerative medicines using adult stem cells for the treatment of heart failure. The company provids heartcel which is a type of stem cell therapy that provides improved outcomes for end-stag …
  • Seven Bank, Ltd.:企業の戦略・SWOT・財務情報
    Seven Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Seven Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Bloomsbury Publishing Plc (BMY):企業の財務・戦略的SWOT分析
    Bloomsbury Publishing Plc (BMY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Electricidade de Mocambique EP:企業の戦略的SWOT分析
    Electricidade de Mocambique EP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • FMC Corp (FMC):企業の財務・戦略的SWOT分析
    FMC Corp (FMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Essilor International S.A.:企業の戦略・SWOT・財務情報
    Essilor International S.A. - Strategy, SWOT and Corporate Finance Report Summary Essilor International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • EXINI Diagnostics AB-医療機器分野:企業M&A・提携分析
    Summary EXINI Diagnostics AB (EXINI), a subsidiary of Progenics Pharmaceuticals Inc, is a healthcare IT company that offers development of software solutions for the medical diagnostic market. The company’s software solutions include EXINIbone, EXINIheart, EXINIbrain and EXINIdat. Its EXINIbone is u …
  • Pristine Sun LLC:電力:M&Aディール及び事業提携情報
    Summary Pristine Sun LLC (Pristine Sun) is a renewable energy company that develops small utility-scale solar PV power plants. The company offers consulting, and project financing and funding services. Its consulting services include solar project development, operation and maintenance, EPC and inst …
  • Litha Healthcare Group Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Litha Healthcare Group Ltd (Litha Healthcare), formerly Myriad Medical Holdings Limited, a subsidiary of Endo International plc is a healthcare company that provides its services to public and private hospitals, pharmacies, general, allied practitioners, and government healthcare programmes. …
  • Showa Shell Sekiyu KK (5002):電力:M&Aディール及び事業提携情報
    Summary Showa Shell Sekiyu KK (Showa Shell) is an energy company. It mainly manufactures and sells oil products and energy related products, such as solar cell products and electricity. The company procures crude oil, refines, stores and sells petroleum products. Its product portfolio includes gasol …
  • Vectren Corporation (VVC)-エネルギー分野:企業M&A・提携分析
    Summary Vectren Corporation (Vectren) is an energy holding company, which carries out the distribution and transmission of natural gas and electricity. Under its wholly owned subsidiary, Vectren Utility Holdings, Inc., the company operates three utilities; Vectren Energy Delivery of Indiana - North …
  • Apetit Oyj:企業の戦略・SWOT・財務情報
    Apetit Oyj - Strategy, SWOT and Corporate Finance Report Summary Apetit Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Eneva SA (ENEV3):企業の財務・戦略的SWOT分析
    Summary Eneva SA (Eneva), formerly MPX Energia SA, is an integrated energy company. The company offers power generation, energy commercialization, and exploration and production of hydrocarbons and natural gas. Its power generation portfolio includes fossil fuels such as coal and natural gas, and re …
  • Marathon Oil Corporation:戦略・SWOT・企業財務分析
    Marathon Oil Corporation - Strategy, SWOT and Corporate Finance Report Summary Marathon Oil Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Gree Inc (3632):企業の財務・戦略的SWOT分析
    Gree Inc (3632) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • L’Occitane International SA:企業の戦略・SWOT・財務情報
    L'Occitane International SA - Strategy, SWOT and Corporate Finance Report Summary L'Occitane International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆